60 Degrees Pharmaceuticals (SXTPW) Common Equity (2022 - 2025)
Historic Common Equity for 60 Degrees Pharmaceuticals (SXTPW) over the last 4 years, with Q3 2025 value amounting to $4.4 million.
- 60 Degrees Pharmaceuticals' Common Equity fell 2570.29% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 2570.29%. This contributed to the annual value of $4.0 million for FY2024, which is 1589.16% down from last year.
- Latest data reveals that 60 Degrees Pharmaceuticals reported Common Equity of $4.4 million as of Q3 2025, which was down 2570.29% from $2.3 million recorded in Q2 2025.
- 60 Degrees Pharmaceuticals' 5-year Common Equity high stood at $7.1 million for Q1 2024, and its period low was -$24.7 million during Q2 2023.
- Moreover, its 4-year median value for Common Equity was $3.5 million (2024), whereas its average is -$5.1 million.
- Its Common Equity has fluctuated over the past 5 years, first skyrocketed by 13334.5% in 2024, then plummeted by 4345.8% in 2025.
- Quarter analysis of 4 years shows 60 Degrees Pharmaceuticals' Common Equity stood at -$24.1 million in 2022, then soared by 119.87% to $4.8 million in 2023, then dropped by 15.89% to $4.0 million in 2024, then increased by 9.78% to $4.4 million in 2025.
- Its Common Equity was $4.4 million in Q3 2025, compared to $2.3 million in Q2 2025 and $4.0 million in Q1 2025.